Prospective monitoring of immune signatures in newly diagnosed high risk multiple myeloma patients under treatment with Isatuximab, Carfilzomib, Lenalidomide and Dexamethasone (I-KRd): First results of the GMMG-CONCEPT trial

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2019-10, Vol.19 (10), p.e141-e142
Main Authors: Asemissen, Anne Marie, Autenrieth, Stella, Bieber, Kristin, Gouttefangeas, Cecile, Rammensee, Hans-Georg, Besemer, Britta, Mann, Christoph, Blau, Igor Wolfgang, Schieferdecker, Aneta, Bokemeyer, Carsten, Goldschmidt, Hartmut, Weisel, Katja
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2152-2650
DOI:10.1016/j.clml.2019.09.236